Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Buehler

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Health Research Policy and Systems|June 20, 2020
Clinical practice guidelines in Brazil - developing a national programmeVerônica Colpani, Sérgio Candido Kowalski, Airton Tetelbom Stein, et al.
Clinics (Sao Paulo, Brazil)|January 9, 2013
Effects of Brazilian Cardioprotective Diet Program on risk factors in patients with coronary heart disease: a Brazilian Cardioprotective Diet randomized pilot trialBernardete Weber, Andrea Polo Galante, Angela Cristine Bersch-Ferreira, et al.
JCO Global Oncology|April 11, 2024
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira StudyDaniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Health Research Policy and Systems|June 20, 2020
Clinical practice guidelines in Brazil - developing a national programmeVerônica Colpani, Sérgio Candido Kowalski, Airton Tetelbom Stein, et al.
Clinics (Sao Paulo, Brazil)|January 9, 2013
Effects of Brazilian Cardioprotective Diet Program on risk factors in patients with coronary heart disease: a Brazilian Cardioprotective Diet randomized pilot trialBernardete Weber, Andrea Polo Galante, Angela Cristine Bersch-Ferreira, et al.
JCO Global Oncology|April 11, 2024
Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira StudyDaniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, et al.
Pageof 3